Skip to main content

Peer Review reports

From: Elevated serum OX40L is a biomarker for identifying corticosteroid resistance in pediatric asthmatic patients

Original Submission
5 Jul 2018 Submitted Original manuscript
6 Sep 2018 Reviewed Reviewer Report - Kirsten Kloepfer
19 Sep 2018 Reviewed Reviewer Report - Yvonne Huang
25 Sep 2018 Author responded Author comments - Su-Li Ma
Resubmission - Version 2
25 Sep 2018 Submitted Manuscript version 2
Publishing
21 Feb 2019 Editorially accepted
19 Mar 2019 Article published 10.1186/s12890-019-0819-5

You can find further information about peer review here.

Back to article page